Androgenetic alopecia, commonly known as pattern hair loss, refers to a genetically influenced condition that causes gradual thinning of the hair on the scalp in both men and women. The androgenetic alopecia market includes all products and services aimed at treating this condition, including pharmaceutical treatments, topical and oral medications, laser and device-based therapies, and emerging regenerative solutions. This market is served by dermatology clinics, hospitals, retail and online pharmacies and direct-to-consumer platforms that offer treatment options aimed at slowing hair loss, promoting regrowth or improving hair density through various mechanisms of action.